Monthly Update3 April 2026 at 07:05 am
Colinz Laboratories Ltd: No Deviation or Variation from Public Issue Proceeds for Q1 FY2025-2026
AI Summary
Colinz Laboratories Ltd has released a statement declaring that Regulation 32 of The SEBI ILDR Regulations, 2015, pertaining to the Statement of Deviation or Variation for proceeds of public issues, rights issues, preferential issues, and QIPs is not applicable to the company for the quarter ended 31.03.2026. This is because the company did not make any public issue, rights issue, preferential issue, or QIP during this period.
Key Highlights
- Colinz Laboratories Ltd has not made any deviations or variations from public issue proceeds for the quarter ended 31.03.2026.
- The company did not conduct any public issues, rights issues, preferential issues, or QIPs during this period.
- Regulation 32 of The SEBI ILDR Regulations, 2015, is not applicable to the company for this quarter.
COLINZPharmaceuticals
COLINZ LABORATORIES LTD.Price Impact